Your browser does not support JavaScript!

Santé humaine biotechnologies domaine d'application

505 entreprises et organismes intervenants dans le domaine 'Santé humaine', classés par activité.

Rejoignez la communauté
Trouvez du matériel
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 1 semaine
Flagship hires Merck veteran to lead AI drug discovery startup
Flagship hires Merck veteran to lead AI drug discovery startup ntaylor Wed, 03/31/2021 - 07:58 ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 2 semaines
Merck sets up $240M Alydia Health buyout to beef up its future Organon women's health spinout
Merck sets up $240M Alydia Health buyout to beef up its future Organon women's health spinout chale Tue, 03/30/2021 - 08:34 ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 3 semaines
Insightful Science buys up former Merck scientists-run Dotmatics to put R&D in the cloud
Insightful Science buys up former Merck scientists-run Dotmatics to put R&D in the cloud badams Tue, 03/23/2021 - 10:14 ...
www.fiercebiotech.com
PFIZER
est cité dans une actualité de FierceBiotech
Il y a 3 semaines
Pfizer ships out two cancer ADCs alongside its tech platform to Pyxis Oncology, and its familiar CEO
Pfizer ships out two cancer ADCs alongside its tech platform to Pyxis Oncology, and its familiar CEO badams Thu, 03/18/2021 - 11:07 ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 3 semaines
Merck taps Amathus in neurodegeneration deal, snagging buyout option
Merck taps Amathus in neurodegeneration deal, snagging buyout option aalidrus Wed, 03/17/2021 - 09:20 ...
www.fiercebiotech.com
SANOFI AVENTIS
est cité dans une actualité de FierceBiotech
Le 17/03/2021
GBT adds 2 Sanofi sickle cell meds to its pipeline in deal worth up to $353M
GBT adds 2 Sanofi sickle cell meds to its pipeline in deal worth up to $353M aalidrus Tue, 03/16/2021 - 09:25 ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 16/03/2021
Gilead, Merck join forces on long-acting HIV treatments
Gilead, Merck join forces on long-acting HIV treatments aalidrus Mon, 03/15/2021 - 09:52 ...
www.fiercebiotech.com
PFIZER
est cité dans une actualité de FierceBiotech
Le 15/03/2021
Prometheus upsizes IPO, fueling chase of Pfizer in bowel disease
Prometheus upsizes IPO, fueling chase of Pfizer in bowel disease ntaylor Fri, 03/12/2021 - 07:34 ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 04/03/2021
Merck must do a new trial for faltering $425M COVID-19 drug the U.S. government asked it to buy
Merck must do a new trial for faltering $425M COVID-19 drug the U.S. government asked it to buy badams Wed, 03/03/2021 - 07:50 ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 03/03/2021
Merck taps tumor-microdosing Presage Biosciences for phase 0 trials
Merck taps tumor-microdosing Presage Biosciences for phase 0 trials aalidrus Tue, 03/02/2021 - 09:35 ...
www.fiercebiotech.com
Charger plus d'actualités